PU21.02 Comparison of HIV incidence in simulated vaccine efficacy trials and observational cohorts using propensity scores in key populations in UgandaPublication OnlyNovel vaccine and other prevention approaches
OA05.03 Compartment specific changes of Innate Lymphoid Cells within the intestinal mucosa of HIV-1 infected individualsOral Abstract SessionMicrobiome & STI: impact on prevention
OA19.02 Construction of a comprehensive bacterial genome catalogue for the female genital tract identifies hundreds of new speciesOral Abstract SessionMicrobiome & STI: impact on prevention
PE06.01 Contraceptive uptake among adolescent girls and young women pre-screened for the MTN-034/ REACH study  E-posterContraception, pregnancy and HIV prevention (incl. PMTCT)
PU25.02 Correlates of adherence to the dapivirine vaginal ring for HIV-1 preventionPublication OnlyProduct acceptability and adherence
PE04.01 Correlates of dapivirine vaginal ring uptake among women participating in an open label extension trial-MTN-025/HOPEE-posterClinical trial results
OA02.02 Correlates of high HIV transmission areas in a generalized hyperendemic setting: findings from a national survey in EswatiniOral Abstract SessionTreatment as prevention
PE19.04 Correlates of STI acquisition during the first years after sexual initiation: a longitudinal cohort study of sexually inexperienced adolescent girls and young women in KenyaE-posterMicrobiome & STI: impact on prevention
PE01.19 Counselors’ acceptability of adherence counseling session recording, fidelity monitoring, and feedback in a multi-site HIV prevention study in four African countriesE-posterBehavioural and social science research
PE07.01 COVID-19 and associated disruptions may indirectly affect HIV outcomes in two capital cities in Western/Central Africa: a modelling studyE-posterCOVID research: Applying lessons from HIV prevention to SARS CoV-2
seek-warrow-warrow-eseek-e91 - 100 of 444 items